In addition to validating STAT as a new goal for chemotherapy of cancer, these combined findings including both in vivo studies and in vitro have also provided the basis for the production of natural component STAT inhibitors (Millimouno et al., 2014). This evidence concerns the gene SOAT1 and cancer.